Atlas market file · Equity · United States
DIEBOLD NIXDORF, IncDBD
- Last close
- 75.38
- Change
- +1.10%
- 96-bar range
- 67.71 – 92.085
- As of
- 7 Aug 2026
DIEBOLD NIXDORF, Inc is a calculating & accounting machines (no electronic computers) issuer listed as DBD on NYSE. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- Nasdaq Trader
- Chart rail
- TradingView
- File state
- Public profile
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
▮ up candle ▮ down candle
Weekly outlook: the last 104 weekly closes (+89.97% over the window).
Source rail: Yahoo Finance chart API (DBD). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView · provider feed Open view ->
Open the attributed TradingView market view for DBD. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
DBD public profile
Calculating & accounting machines (no electronic computers) issuer. DIEBOLD NIXDORF, Inc is connected to current market context, cited company sources and its retained research file.
DIEBOLD NIXDORF, Inc trades as DBD on NYSE. DIEBOLD NIXDORF, Inc (DBD) has a latest verified close of 75.38, up 1.10%, dated 7 Aug 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. Atlas files DBD under USA Stocks for browsing.
What changed for DIEBOLD NIXDORF, Inc today
Diebold Nixdorf reported $891.8 million in revenue for the quarter ending 31 March 2026, but the headline masks a thin operating profit of $32.7 million and net income of just $5 million. The company’s cash position stands at $358.6 million, while its inventory has ballooned to $553.1 million-an increase of $38.7 million in a single quarter. Earnings per diluted share came in at $0.14 on 35.7 million shares outstanding. What looks like a cash-rich balance sheet is offset by a balance sheet that smells suspiciously like unsold terminals and overstocked branches.
What Diebold Nixdorf actually does is sell and service self-service technology: ATMs, kiosks, retail checkouts, and reverse vending machines, all wrapped in a support promise that sounds slicker than the reality. Its ‘eServices Portal’ and ‘Global Customer Experience Centers’ are meant to project a future where machines hum along, customers smile, and engineers sip espresso while debugging firmware. The evidence shows a different scene: a $22.1 million R&D budget, a services desk that logs real-world failures, and a product lineup that still relies on foot traffic in malls, banks, and supermarkets-venues that are not exactly booming. The company’s narrative is ‘omnichannel transformation’, but the filings read like ‘omni-channel inventory accumulation’.
The latest 10-Q gives us the numbers, the 13D/A gives us the management desks drama, and the product pages give us the polished brochure. The revenue number is real; the net income is real; the inventory build is real; the board’s interest is real. The gap between the platform story and the balance sheet is the only thing here that’s truly outsized. Revenue: $891.8M (source: 10-Q, period ending 2026-03-31, https://www.sec.gov/Archives/edgar/data/28823/000095012326004599/xslF345X06/form10q.html). Net income: $5.0M (source: 10-Q, period ending 2026-03-31, https://www.sec.gov/Archives/edgar/data/28823/000095012326004599/xslF345X06/form10q.html). Inventory net: $553.1M, up $38.7M (source: 10-Q, period ending 2026-03-31, https://www.sec.gov/Archives/edgar/data/28823/000095012326004599/xslF345X06/form10q.html). EPS diluted: $0.14 (source: 10-Q, period ending 2026-03-31, https://www.sec.gov/Archives/edgar/data/28823/000095012326004599/xslF345X06/form10q.html).
The company’s investor-relations page points to ‘News & Events’ and ‘Customer Experience Centers’ as proof of momentum, but the actual evidence trail is thinner than a printed receipt. The centres are real places you can visit, and the newsroom is real, but neither changes the fact that the latest hard numbers are the 10-Q. The portal pages for ‘eServices Portal Remote’ and the ‘Services Support Desk’ describe what the product is supposed to do; they do not supply revenue, profit, or order intake. The SEC filings are the only source that supplies audited figures, and they show a business that is profitable on paper but still lugging around an inventory load that smells like the last decade’s orders.
The website’s visual rail includes a glossy shot of a bright, futuristic Customer Experience Center, but the balance sheet is stuck in the present: $2.80 billion in liabilities against $1.02 billion in equity. The cash flow from operations is $31.7 million, which is enough to keep the lights on but not enough to fund a moonshot. The board’s 13D/A filing on 26 June 2026 suggests a push for change, yet the operating metrics remain stubbornly middle-aged. The gap between the marketing video and the 10-Q is not a bug; it is the company’s current business model.
The evidence does not show a breakout product launch, a regulatory tailwind, or a surge in orders. What it does show is a company selling hardware into sectors-banking, retail, recycling-that are structurally challenged by e-commerce, cashless trends, and rising interest costs. The ‘eServices Portal’ may be a genuine software offering, but the $22.1 million R&D line does not scream ‘disruptor’; it screams ‘defensive maintenance’. The ‘Global Customer Experience Centers’ are real, but they are not a substitute for audited revenue growth.
If Diebold Nixdorf’s next quarter brings a clear uptick in orders, a reduction in inventory, or a credible path to net profitability above $10 million, the file will change. Until then, the balance sheet remains the single source of truth, and it is telling a story that the brochures have not yet caught up with.
Sources & evidence · 10 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
DBD technical readout
Directional bias up. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.
Open an Atlas research path on DBD
FreedomCore Atlas can expand this public profile into source-led research files with company snapshots, valuation context, filings and segment detail, source packs, and equity briefs. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep DBD research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
DBD FAQ
What is DIEBOLD NIXDORF, Inc (DBD)?DIEBOLD NIXDORF, Inc (DBD) has a latest verified close of 75.38, up 1.10%, dated 7 Aug 2026. Use this page to check the price chart, company context, source-backed...
DIEBOLD NIXDORF, Inc (DBD) has a latest verified close of 75.38, up 1.10%, dated 7 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for DBD?DIEBOLD NIXDORF, Inc (DBD) has a latest verified close of 75.38, up 1.10%, dated 7 Aug 2026. It brings the latest available chart, company context, cited sources, risks...
DIEBOLD NIXDORF, Inc (DBD) has a latest verified close of 75.38, up 1.10%, dated 7 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. Atlas files DBD under USA Stocks for browsing.
How often is the DBD page updated?The DBD public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The DBD public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for DBD?The DBD file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NYSE:DBD. SEC EDGAR provides the filing anchor for this issuer. The page separates verified...
The DBD file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NYSE:DBD. SEC EDGAR provides the filing anchor for this issuer. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on DBD?Yes. The workstation can open DBD, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open DBD, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this DBD page investment advice?No. The DBD page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...
No. The DBD page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →
DBD
Equity · evidence first